Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats

Journal of Parasitology

Volumn 82, Issue 1, 1996, Pages 158-162

  Rehg, Jerold E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; DEXAMETHASONE; DIETHYLDITHIOCARBAMIC ACID; EFLORNITHINE; IMMUNOMODULATING AGENT; IVERMECTIN; LEVAMISOLE; THALIDOMIDE; TIABENDAZOLE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BILIARY TRACT INFECTION; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DOSE RESPONSE; DRUG EFFICACY; FEMALE; ILEUM DISEASE; IMMUNE DEFICIENCY; INTESTINE INFECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; COMMON BILE DUCT; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DITIOCARB; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; FEMALE; IMMUNOSUPPRESSION; INTESTINAL DISEASES, PARASITIC; INTESTINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; CRYPTOSPORIDIUM PARVUM;

EID: 0029921861     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.2307/3284133     Document Type: Article

References (36)

1. ARMSTRONG, D., J. W. M. GOLD, J. DRYJANSKI, E. WHIMBEY, B. POLSKY, C. HAWKINS, A. E. BROWN, E. BERNARD, AND T. E. KIEHN. 1985. Treatment of infections in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 103: 738-743.
2. BLAKLEY, B. R., AND C. G. ROUSSEAUX. 1991. Effect of ivermectin on the immune response in mice. American Journal of Veterinary Research 52: 593-595.
3. BRASSEUR, P., D. LEMETEIL, AND J. BALLET. 1991. Anticryptosporidial drug activity screened with an immunosuppressed rat model. Journal of Protozoology 38: 230S-231S.
4. BRUNNER, C. J., AND C. C. MUSCOPLAT. 1980. Immunomodulatory effects of levamisole. Journal of the American Veterinary Medical Association 176: 1159-1162.
5. + cells. AIDS 5: 1453-1461.
6. CLARKSON, A. B., JR., J. SARIC, AND R. W. GRADY. 1990. Deferoxamine and eflornithine (DL-α-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy 34: 1833-1835.
7. CONOVER, W. J. 1980. Practical nonparametric statistics, John Wiley & Sons, Inc., New York, New York, p. 1-493.
8. DEL MAR SANZ, M., R. RUBIO, A. CASILLAS, C. GUIJARRO, J. R. COSTA, R. MARTINEZ, AND J. DE DIOS GARCIA. 1991. Visceral leishmaniasis in HIV-infected patients. AIDS 5: 1272-1274.
9. PAYER, R., AND W. ELLIS. 1993. Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves. Journal of Parasitology 79: 771-774.
10. _, P. H. KLESIUS, AND C. ANDREWS. 1987. Efficacy of bovine transfer factor to protect neonatal calves against experimentally induced clinical cryptosporidiosis. Journal of Parasitology 73: 1061-1062.
11. _, AND B. L. P. UNGAR. 1986. Cryptosporidium spp. and cryptosporidiosis. Microbiological Reviews 50: 458-483.
12. FEGIES, M., AND J. GUERRERO. 1977. Treatment of toxoplasmosis with levamisole. Transactions of the Royal Society of Tropical Medicine and Hygiene 71: 178-179.
13. GUNZLER, V. 1989. Thalidomide-A therapy for the immunological consequences of HIV infection? Medical Hypotheses 30: 105-109.
14. HAMER, D. H., H. WARD, S. TZIPORI, M. E. A. PEREIRA, J. P. ALROY, AND G. T. KEUSCH. 1994. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infection and Immunity 62: 2208-2213.
15. HERSH, E. M., G. BREWTON, D. ABRAMS, J. BARTLETT, J. GALPIN, P. GILL, R. GORTER, M. GOTTLIEB, J. J. JONIKAS, S. LANDESMAN, A. LEVINE, A. MARCEL, E. A. PETERSON, M. WHITESIDE, J. ZAHRADNIK, C NEGRON, F. BOUTITIE, J. CARAUX, J.-M. DUPUY, AND R. SALMI. 1991. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. Journal of the American Medical Association 265: 1538-1544.
16. _, AND D. E. MOSIER. 1990. Biological activity of diethyldithiocarbamate (Ditiocarb. Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. Developments in Biological Standardization 72: 355-363.
17. HUBNER, L., M. ERNST, D. VON LAER, S. SCHWANDER, AND H. D. FLAD. 1991. Enhancement of monocyte antimycobacterial activity by diethyldithiocarbamate (DTC). International Journal of Immunopharmacology 13: 1067-1072.
18. HUGHES, W. T., AND B. L. SMITH. 1984. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrobial Agents and Chemotherapy 26: 436-440.
19. LEID, R. W., C. M. SUQUET, AND L. TANIGOSHI. 1989. Oxygen detoxifying enzymes in parasites: A review. Acta Leidensia 57: 107-114.
20. LONS DANIC, D., V. LAVARDE, M. CHAHAL, M. C. ISENI, O. MARTY, AND M. KAZATCHKINE. 1991. Strongyloidiasis infection in HIV infected patients. International Conference on AIDS 7: 255.
21. LUNDY, J., AND E. J. LOVETT, III. 1978. Immunomodulation with thiabendazole: A review of immunologic properties and efficacy in combined modality cancer therapy. Cancer Treatment Reports 62: 1955-1962.
22. NACIRI, M., R. MANCASSOLA, P. YVORE, AND J. E. PEETERS. 1993. The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves. Veterinary Parasitology 45: 199-207.
23. RASMUSSEN, K. R., E. G. MARTIN, M. J. ARROWOOD, AND M. C. HEALEY. 1991. Effects of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. Journal of Protozoology 38: 157S-159S.
24. REHG, J. E. 1991a. Anti-cryptosporidial activity of macrolides in immunosuppressed rats. Journal of Protozoology 38: 228S-230S.
25. _. 1991b. Anticryptosporidial activity is associated with specific sulfonamides in immunosuppressed rats. Journal of Parasitology 77: 238-240.
26. _. 1994. New potential therapies for cryptosporidiosis: An analysis of variables affecting drug efficacy. Folia Parasitologica 41: 23-26.
27. _, M. L. HANCOCK, AND D. B. WOODMANSEE. 1988. Characterization of a dexamethasone-treated rat model of cryptosporidial infection. Journal of Infectious Diseases 158: 1406-1407.
28. REISINGER, E. C., P. KERN, M. ERNST, P. BOCK, H. D. FLAD, AND M. DIETRICH. 1990. Inhibition of HIV progression by dithiocarb. Lancet 335: 679-682.
29. RENOUX, G., M. RENOUX, Y. LEBRANCHU, AND P. BARDOS. 1982. Immunopharmacology of DTC in mice and men. In Immunomodulatory drugs and modifiers of the biological response. B. Serrou and I. Rosenfeld (eds.). Elsevier Biomedical Press, Amsterdam, Netherlands, p. 113-132.
30. SAXON, A. 1987. Oral administration of bovine colostrum anti-cryptosporidia antibody fails to alter the course of human cryptosporidiosis. Journal of Parasitology 73: 413-415.
31. SHARKIS, S. J., G. D. LUK, AND M. I. COLLECTOR. 1983. Regulation of hematopoiesis II: The role of polyamine inhibition on helper or suppressor influences of the thymus. Blood 61: 604-607.
32. SMITH, P. D., H. C. LANE, V. J. GILL, J. F. MANISCHEWITZ, G. V. QUINNAN, A. S. FAUCI, AND H. MASUR. 1988. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS); etiology and response to therapy. Annals of Internal Medicine 108: 328-333.
33. SUNDERMAN, F. W. 1979. Efficacy of sodium diethyldithiocarbamate (dithiocarb) in acute nickel carbonyl poisoning. Annals of Clinical and Laboratory Science 9: 1-10.
34. _. 1991. Therapeutic properties of sodium diethyldithiocarbamate: Its role as an inhibitor in the progression of AIDS. Annals of Clinical and Laboratory Science 21: 70-81.
35. UNGAR, B. L. P. 1990. Cryptosporidiosis in humans (Homo sapiens). In Cryptosporidiosis of man and animals, J. P. Dubey, C. A. Speer, and R. Fayer (eds.). CRC Press, Boca Raton, Florida, p. 59-82.
36. VICENTE, T., A. ORTEGA, P. MUNOZ, M. D. DIAZ, AND E. BOUZA. 1993. In vitro activity of thalidomide against Mycobacterium avium complex. Archives of Internal Medicine 153: 534-534.